CompletedNot Applicable

ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore

Singapore125 participantsStarted 2022-02-14

Plain-language summary

To pilot a culturally adapted version of ENABLE (6-month program) for Heart Failure (HF) patients and caregivers in the inpatient and outpatient setting in Singapore. The investigators aim to determine the feasibility of trial procedures and assess the acceptability and preliminary efficacy of ENABLE with a randomized wait-list controlled trial design.

Who can participate

Age range21 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 21 years or older.
✓. Able to communicate in English or Chinese.
✓. Have a diagnosis of HF (stage C or D) by the American College of Cardiology guidelines and be of New York Heart Association (NYHA) stage 2, 3 or 4 functional statuses.
✓. Have an expected prognosis of at least 6 months.
✓. Be on disease directed HF management.
✓. Have had a hospitalization event within 6 months prior to recruitment.
✓. 21 years or older.
✓. Able to communicate in English or Chinese.

Exclusion criteria

✕. Patients who are unable to give informed consent
✕. Patients who are already known to a palliative care service.
✕. Caregivers who are unable to give informed consent.
✕. Caregivers who are domestic helpers.

What they're measuring

Feasibility of trial procedures - percentage of patients and caregivers that are recruited, successfully randomized, and able to complete the ENABLE program

Timeframe: 6 months.

Acceptability of ENABLE program - through completion of the client satisfaction questionnaire (CSQ-4)

Timeframe: 6 months.

The possible efficacy of the ENABLE program- through evaluating change in patient quality of life (QOL) at 6 months as compared to baseline (assessed using the Kansas City Cardiomyopathy Questionnaire - KCCQ)

Timeframe: 6 months.

Trial details

NCT IDNCT05211882

SponsorNational Cancer Centre, Singapore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-25

View on ClinicalTrials.gov More Heart Failure trials

Plain-language summary

Who can participate

Age range21 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 21 years or older.
✓. Able to communicate in English or Chinese.
✓. Have a diagnosis of HF (stage C or D) by the American College of Cardiology guidelines and be of New York Heart Association (NYHA) stage 2, 3 or 4 functional statuses.
✓. Have an expected prognosis of at least 6 months.
✓. Be on disease directed HF management.
✓. Have had a hospitalization event within 6 months prior to recruitment.
✓. 21 years or older.
✓. Able to communicate in English or Chinese.

Exclusion criteria

✕. Patients who are unable to give informed consent
✕. Patients who are already known to a palliative care service.
✕. Caregivers who are unable to give informed consent.
✕. Caregivers who are domestic helpers.

What they're measuring

Feasibility of trial procedures - percentage of patients and caregivers that are recruited, successfully randomized, and able to complete the ENABLE program

Timeframe: 6 months.

Acceptability of ENABLE program - through completion of the client satisfaction questionnaire (CSQ-4)

Timeframe: 6 months.